An unproven technique with potentially fatal outcome: Provocation/neutralization in a patient with systemic mastocytosis

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 1, 1999, Pages 61-65

  Teuber, Suzanne S ^a,b   Vogt, Phillip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; PROVOCATION TEST; RISK ASSESSMENT; SYSTEMIC MASTOCYTOSIS; TREATMENT INDICATION;

EID: 0032944427     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62662-2     Document Type: Article

References (16)

1. Fricker M, Helbling A, Schwanz L, Müller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997;100:11-15.
2. Willoughby JW. Provocative food test technique. Ann Allergy 1965;23: 543-553.
3. King WP, Rubin WA, Fadal RG et al. Provocation-neutralization: a two-part study. Part I. The intracutaneous provocative food test: a multi-center comparison study. Otolaryngol Head Neck Surg 1988;99:263-271.
4. King WP, Rubin WA, Fadal RG, et al. Provocation-neutralization: a two-part study. Part II. Subcutaneous neutralization therapy: a multi-center study. Otolaryngol Head Neck Surg 1988;99: 272-277.
5. th edition. St. Louis, Missouri: Mosby, 1998:1240-1242.
6. AAAI Board of Directors, Position Statement. Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts. J Allergy Clin Immunol 1994; 93:811-812.
7. Joint Task Force on Practice Parameters, The Diagnosis and Management of Anaphylaxis. Algorithm for the treatment of acute anaphylaxis. J Allergy Clin Immunol 1998;101: S469-471.
8. Baram P, Rashkovsky M, Hershkoviz R, et al. Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clin Exp Immunol 1997;110: 485-491.
9. Abraham WM, Abraham MK, Ahmed T. Protective effect of heparin on immunologically induced tracheal smooth muscle contraction in vitro. Int Arch Allergy Immunol 1996;110: 79-84.
10. Diamant Z, Timmers ML, van der Veen H, et al. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med 1996;153:1790-1795.
11. Jewett DL, Fein G, Greenberg MH. A double-blind study of symptom provocation to determine food sensitivity. N Engl J Med 1990;323:429-433.
12. Ferguson A. Food sensitivity or self-deception? N Engl J Med 1990;323: 476-478.
13. Green M. Sublingual provocative testing for food and FD and C dyes. Ann Allergy 1974;33:274.
14. Ball FI. Telangiectasia macularis eruptiva perstans: report of an early stage in a child. Arch Dermatol Syphilol 1937; 36:65-69.
15. Soter NA. The skin in mastocytosis. J Invest Dermatol 1991;96:32S-39S.
16. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96:2S-4S.